May 9 |
We're Not Very Worried About Janux Therapeutics' (NASDAQ:JANX) Cash Burn Rate
|
May 8 |
Janux Therapeutics Reports Narrower Q1 Loss, Misses Revenue Estimates
|
May 7 |
Janux Therapeutics GAAP EPS of -$0.30 beats by $0.03
|
May 7 |
Janux Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights
|
May 2 |
Janux Therapeutics gains amid renewed takeover speculation
|
Apr 30 |
Here's What Could Help Janux Therapeutics (JANX) Maintain Its Recent Price Strength
|
Apr 29 |
Janux Therapeutics jumps as much as 28% on heels of Deciphera buyout deal
|
Apr 17 |
Take the Money and Run: 3 Overbought Stocks to Sell ASAP
|
Apr 16 |
Janux a new buy at Jones on lead assets for solid tumors
|
Apr 16 |
These 3 Biotech Stocks Are Up 269% in 2024. Is There More to Come?
|